Morphine Sulfate
Product Images NDC 0409-1135

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0409-1135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Morphine 01)

Chemical structure of Morphine Sulfate, showing the molecular arrangement including aromatic and hydroxyl groups, nitrogen-containing rings, and sulfate hydrate components represented as H2SO4 and 5H2O.*

FDA Label Image

Logo (Morphine 02)

FDA Label Image

Principal Display Panel (1000 mg/20 mL Vial Label)

Label for Morphine Sulfate Injection, USP, 1000 mg per 20 mL (50 mg/mL) single-dose fliptop vial by Hospira, Inc. Contains warnings for intravenous use only and dilution, with specific caution against intrathecal or epidural use and direct injection. Additional formulation details and storage instructions are included.*

FDA Label Image

Principal Display Panel (1000 mg/20 mL Vial Carton)

Morphine Sulfate Injection, USP 1000 mg/20 mL (50 mg/mL) single-dose fliptop vial packaging label. The label includes warnings such as 'For intravenous use only,' 'Not for intrathecal or epidural use,' and 'Contains sulfites.' Manufactured by Hospira, Inc. The label also lists storage instructions and mentions the presence of preservatives and pH adjustment components.*

FDA Label Image

Principal Display Panel (2500 mg/50 mL Vial Label)

Morphine Sulfate injection USP label by Hospira, Inc. The label indicates a 50 mL single-dose fliptop vial with a concentration of 50 mg/mL (total 2500 mg/50 mL). It includes warnings for intravenous use only and cautions against intrathecal, epidural, or direct injection. Additional information on contents, storage, and usability is also provided.*

FDA Label Image

Principal Display Panel (2500 mg/50 mL Vial Carton)

Packaging label for Morphine Sulfate Injection, USP 2500 mg/50 mL (50 mg/mL) single-dose fliptop vial by Hospira, Inc. The label specifies intravenous use only with warnings against intrathecal or epidural use. It includes storage instructions, ingredient content, and cautions related to sulfite content and injection appearance.*

FDA Label Image

Principal Display Panel (250 mg Vial Label)

Label of Morphine Sulfate Inj., USP (25 mg/mL) in a 10 mL fill single-dosage fliptop vial by Hospira, Inc. The label includes warnings about habit-forming potential and cautions for dilution and injection. It also shows concentration details, storage instructions, and the Hospira logo.*

FDA Label Image

Principal Display Panel (250 mg Vial Carton)

Packaging label for Morphine Sulfate Injection, USP, 25 mg/mL, total 10 mL fill in a single-dose fliptop vial. The label shows 250 mg total content, preservative-free, with warnings about habit forming and use only for dilution, not direct injection. Manufactured by Hospira, Inc., Lake Forest, IL, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.